Multidrug-resistant Escherichia coli in Asia: Epidemiology and management

Expert Review of Anti-Infective Therapy

Volumn 13, Issue 5, 2015, Pages 575-591

  Sidjabat, Hanna E ^a   Paterson, David L ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

AmpC; Asia; Carbapenemase; ESBL; Management; Molecular epidemiology; Multidrug resistant Escherichia coli

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE AMPC; BETA LACTAMASE CTX M; CARBAPENEM DERIVATIVE; CARBAPENEMASE; CEFOXITIN; CEPHALOSPORIN DERIVATIVE; CEPHAMYCIN; CIPROFLOXACIN; CLAVULANIC ACID; CLOXACILLIN; COLISTIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN; GENTAMICIN; LEVOFLOXACIN; METALLO BETA LACTAMASE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULBACTAM; SULFONAMIDE; TAZOBACTAM; TETRACYCLINE; TIGECYCLINE; UNINDEXED DRUG; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ASIA; BACTERIAL COLONIZATION; ENZYME SYNTHESIS; ESCHERICHIA COLI INFECTION; EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI; HUMAN; INDIA; KLEBSIELLA PNEUMONIAE; MICROBIOME; MOLECULAR CLONING; MULTIDRUG RESISTANT ESCHERICHIA COLI; NONHUMAN; PREVALENCE; REVIEW; SEQUENCE ANALYSIS; URINARY TRACT INFECTION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; MULTIDRUG RESISTANCE; PATHOGENICITY;

ANTI-BACTERIAL AGENTS; ASIA; BETA-LACTAMASES; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS;

EID: 84927661124     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.2015.1028365     Document Type: Review

References (196)

1. Pitout JD. Extraintestinal pathogenic escherichia coli: a combination of virulence with antibiotic resistance. Front Microbiol 2012;3:9
2. Qureshi ZA, Paterson DL, Peleg AY, et al. Clinical characteristics of bacteraemia caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in the era of CTX-M-type and KPC-type beta-lactamases. Clin Microbiol Infect 2012;18:887-93
3. Kuenzli E, Jaeger VK, Frei R, et al. High colonization rates of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli in Swiss travellers to South Asia-a prospective observational multicentre cohort study looking at epidemiology, microbiology and risk factors. BMC Infect Dis 2014;14:528
4. Hopkins KL, Davies RH, Threlfall EJ. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int J Antimicrob Agents 2005;25:358-73
5. Frost LS, Leplae R, Summers AO, et al. Mobile genetic elements: the agents of open source evolution. Nat Rev Microbiol 2005;3:722-32
6. Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 2011;66:1-14
7. Canton R, Coque TM. The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 2006;9:466-75
8. Woodford N, Carattoli A, Karisik E, et al. Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone. Antimicrob Agents Chemother 2009;53:4472-82
9. Qureshi ZA, Doi Y. Escherichia coli sequence type 131: epidemiology and challenges in treatment. Expert Rev Anti Infect Ther 2014;12:597-609
10. Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009;53:5046-54
11. Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001;45:1151-61
12. Cai JC, Zhang R, Hu YY, et al. Emergence of Escherichia coli sequence type 131 isolates producing KPC-2 carbapenemase in China. Antimicrob Agents Chemother 2014;58: 1146-52
13. Peirano G, Bradford PA, Kazmierczak KM, et al. Global incidence of carbapenemase-producing Escherichia coli ST131. Emerg Infect Dis 2014;20:1928-31
14. β-Lactamase Classification and Amino acid sequences for TEM, SHV and OXA extended-spectrum and inhibitor resistant enzymes. Available from: www. lahey.org/Studies/.html
15. Bush K, Jacoby GA. Updated functional classification of beta-lactamases. Antimicrob Agents Chemother 2010;54:969-76
16. Lahey hospital & medical center. Available from: www.lahey.org/Studies/temtable.asp
17. Tzouvelekis LS, Bonomo RA. SHV-type beta-lactamases. Curr Pharm Des 1999;5: 847-64
18. Jarlier V, Nicolas MH, Fournier G, et al. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988;10:867-78
19. Canton R, Gonzalez-Alba JM, Galan JC. CTX-M Enzymes: origin and Diffusion. Front Microbiol 2012;3:110
20. Karim A, Poirel L, Nagarajan S, et al. Plasmid-mediated extended-spectrum beta-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol Lett 2001;201: 237-41
21. Peirano G, Pitout JD. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 2010;35:316-21
22. Coque TM, Novais A, Carattoli A, et al. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg Infect Dis 2008;14:195-200
23. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, et al. Intercontinental emergence of Escherichia coli clone O25: H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008;61:273-81
24. Hu YY, Cai JC, Zhou HW, et al. Molecular typing of CTX-M-producing escherichia coli isolates from environmental water, swine feces, specimens from healthy humans, and human patients. Appl Environ Microbiol 2013;79:5988-96
25. Leflon-Guibout V, Blanco J, Amaqdouf K, et al. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J Clin Microbiol 2008;46: 3900-5
26. Johnson JR, Nicolas-Chanoine MH, DebRoy C, et al. Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. Emerg Infect Dis 2012;18:598-607
27. Sidjabat HE, Seah KY, Coleman L, et al. Expansive spread of IncI1 plasmids carrying blaCMY-2 amongst Escherichia coli. Int J Antimicrob Agents 2014;44:203-8
28. Poirel L, Potron A, Nordmann P. OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother 2012;67: 1597-606
29. Kim YA, Qureshi ZA, Adams-Haduch JM, et al. Features of infections due to Klebsiella pneumoniae carbapenemase-producing Escherichia coli: emergence of sequence type 131. Clin Infect Dis 2012;55:224-31
30. Nordmann P, Naas T, Poirel L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011;17:1791-8
31. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009;9:228-36
32. Wailan AM, Paterson DL. The spread and acquisition of NDM-1: a multifactorial problem. Expert Rev Anti Infect Ther 2014;12:91-115
33. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010;10:597-602
34. Sartor AL, Raza MW, Abbasi SA, et al. Molecular Epidemiology of NDM-1-Producing Enterobacteriaceae and Acinetobacter baumannii Isolates from Pakistan. Antimicrob Agents Chemother 2014;58:5589-93
35. Sidjabat H, Nimmo GR, Walsh TR, et al. Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-beta-lactamase. Clin Infect Dis 2011;52:481-4
36. Albur M, Noel A, Bowker K, et al. Bactericidal activity of multiple combinations of tigecycline and colistin against NDM-1-producing Enterobacteriaceae. Antimicrob Agents Chemother 2012;56:3441-3
37. Wang D, Chen J, Yang L, et al. Phenotypic and Enzymatic Comparative Analysis of the KPC Variants, KPC-2 and Its Recently Discovered Variant KPC-15. PLoS One 2014;9:e111491
38. Hornsey M, Phee L, Wareham DW. A novel variant, NDM-5, of the New Delhi metallo-beta-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob Agents Chemother 2011;55:5952-4
39. Nakano R, Nakano A, Hikosaka K, et al. First Report of Metallo-beta-Lactamase NDM-5 producing escherichia coli in Japan. Antimicrob Agents Chemother 2014; 58(12):7611-12
40. Rogers BA, Sidjabat HE, Silvey A, et al. Treatment options for new delhi metallo-beta-lactamase-harboring enterobacteriaceae. Microb Drug Resist 2013;19:100-3
41. Tada T, Miyoshi-Akiyama T, Dahal RK, et al. NDM-8 metallo-beta-lactamase in a multidrug-resistant Escherichia coli strain isolated in Nepal. Antimicrob Agents Chemother 2013;57:2394-6
42. Williamson DA, Sidjabat HE, Freeman JT, et al. Identification and molecular characterisation of New Delhi metallo-beta-lactamase-1 (NDM-1)-and NDM-6-producing Enterobacteriaceae from New Zealand hospitals. Int J Antimicrob Agents 2012;39:529-33
43. Tada T, Shrestha B, Miyoshi-Akiyama T, et al. NDM-12, a novel New Delhi metallo-beta-lactamase variant from a carbapenem-resistant Escherichia coli clinical isolate in Nepal. Antimicrob Agents Chemother 2014;58:6302-5
44. Ma L, Siu LK, Lin JC, et al. Updated molecular epidemiology of carbapenem-non-susceptible Escherichia coli in Taiwan: first identification of KPC-2 or NDM-1-producing E. coli in Taiwan. BMC Infect Dis 2013;13:599
45. Hassan H, Abdalhamid B. Molecular characterization of extended-spectrum beta-lactamase producing Enterobacteriaceae in a Saudi Arabian tertiary hospital. J Infect Developing Ctries 2014;8:282-8
46. Hussain A, Ranjan A, Nandanwar N, et al. Genotypic and phenotypic profiles of Escherichia coli isolates belonging to clinical ST131, clinical non-ST131 and faecal non-ST131 lineages from India. Antimicrob Agents Chemother 2014;58(12):7240-9
47. Kim S, Sung JY, Cho HH, et al. Characterization of CTX-M-14 and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae isolates from urine specimens in a tertiary-care hospital. J Microbiol Biotechnol 2014;24:765-70
48. Li B, Sun JY, Liu QZ, et al. High prevalence of CTX-M beta-lactamases in faecal Escherichia coli strains from healthy humans in Fuzhou, China. Scand J Infect Dis 2011;43:170-4
49. Severin JA, Mertaniasih NM, Kuntaman K, et al. Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia. J Antimicrob Chemother 2010;65:465-9
50. Zhao WD, Yan P, Guan HN, et al. Characterization of CTX-M-type extended-spectrum beta-lactamase in clinical clones of Escherichia coli in Southwest China. J Basic Microbiol 2014;54:247-52
51. Netikul T, Sidjabat HE, Paterson DL, et al. Characterization of an IncN2-type blaNDM-1-carrying plasmid in Escherichia coli ST131 and Klebsiella pneumoniae ST11 and ST15 isolates in Thailand. J Antimicrob Chemother 2014;69(11):3161-3
52. Perry JD, Naqvi SH, Mirza IA, et al. Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media. J Antimicrob Chemother 2011;66:2288-94
53. Teo J, Ngan G, Balm M, et al. Molecular characterization of NDM-1 producing Enterobacteriaceae isolates in Singapore hospitals. Western Pac Surveill Response J 2012;3:19-24
54. Islam MA, Talukdar PK, Hoque A, et al. Emergence of multidrug-resistant NDM-1-producing Gram-negative bacteria in Bangladesh. Eur J Clin Microbiol Infect Dis 2012;31:2593-600
55. World Bank. Population Total. Retreived 8 November 2014
56. Shen D, Winokur P, Jones RN. Characterization of extended spectrum beta-lactamase-producing Klebsiella pneumoniae from Beijing, China. Int J Antimicrob Agents 2001;18:185-8
57. Xiong Z, Zhu D, Wang F, et al. Investigation of extended-spectrum beta-lactamase in Klebsiellae pneumoniae and Escherichia coli from China. Diagn Microbiol Infect Dis 2002;44:195-200
58. Li CR, Li Y, Zhang PA. Dissemination and spread of CTX-M extended-spectrum beta-lactamases among clinical isolates of Klebsiella pneumoniae in central China. Int J Antimicrob Agents 2003;22:521-5
59. Sheng WH, Badal RE, Hsueh PR, et al. Distribution of extended-spectrum beta-lactamases, AmpC beta-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother 2013;57:2981-8
60. Xia S, Fan X, Huang Z, et al. Dominance of CTX-M-type extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolated from patients with community-onset and hospital-onset infection in China. PLoS One 2014;9: e100707
61. Zhang L, Lu X, Zong Z. The emergence of blaCTX-M-15-carrying Escherichia coli of ST131 and new sequence types in Western China. Ann Clin Microbiol Antimicrob 2013;12:35
62. Zong Z, Yu R. bla(CTX-M)-carrying Escherichia coli of the O25b ST131 clonal group have emerged in China. Diagn Microbiol Infect Dis 2011;69:228-31
63. Sun Y, Zeng Z, Chen S, et al. High prevalence of bla(CTX-M) extended-spectrum beta-lactamase genes in Escherichia coli isolates from pets and emergence of CTX-M-64 in China. Clin Microb Infect 2010;16:1475-81
64. Liu W, Chen L, Li H, et al. 2009;Novel CTX-M {beta}-lactamase genotype distribution and spread into multiple species of Enterobacteriaceae in Changsha, Southern China. J Antimicrob Chemother 2009;63:895-900
65. Ding H, Yang Y, Lu Q, et al. The prevalence of plasmid-mediated AmpC beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from five children's hospitals in China. Eur J Clin Microbiol Infect Dis 2008;27:915-21
66. Han C, Yang Y, Wang M, et al. The prevalence of plasmid-mediated quinolone resistance determinants among clinical isolates of ESBL or AmpC-producing Escherichia coli from Chinese pediatric patients. Microbiol Immunol 2010;54:123-8
67. Li Y, Li Q, Du Y, et al. Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC beta-lactamase resistance in China. J Clin Microbiol 2008;46:1317-21
68. Wei ZQ, Du XX, Yu YS, et al. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother 2007;51:763-5
69. Hu L, Zhong Q, Shang Y, et al. The prevalence of carbapenemase genes and plasmid-mediated quinolone resistance determinants in carbapenem-resistant Enterobacteriaceae from five teaching hospitals in central China. Epidemiol Infect 2014;142:1972-7
70. Qi Y, Wei Z, Ji S, et al. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother 2011;66:307-12
71. Chen L, Hu H, Chavda KD, et al. Complete sequence of a KPC-producing IncN multidrug-resistant plasmid from an epidemic Escherichia coli sequence type 131 strain in China. Antimicrob Agents Chemother 2014;58:2422-5
72. Li G, Wei Q, Wang Y, et al. Novel genetic environment of the plasmid-mediated KPC-3 gene detected in Escherichia coli and Citrobacter freundii isolates from China. Eur J Clin Microbiol Infect Dis 2011;30: 575-80
73. Yang J, Chen Y, Jia X, et al. Dissemination and characterization of NDM-1-producing Acinetobacter pittii in an intensive care unit in China. Clin Microbiol Infect 2012;18: E506-13
74. Ho PL, Li Z, Lai EL, et al. Emergence of NDM-1-producing Enterobacteriaceae in China. J Antimicrob Chemother 2012;67: 1553-5
75. Qin S, Fu Y, Zhang Q, et al. High incidence and endemic spread of NDM-1-positive enterobacteriaceae in henan province, China. Antimicrob Agents Chemother 2014;58:4275-82
76. Zhou G, Guo S, Luo Y, et al. NDM-1-producing strains, family Enterobacteriaceae, in hospital, Beijing, China. Emerg Infect Dis 2014;20:340-2
77. Ho PL, Yeung MK, Lo WU, et al. Predominance of pHK01-like incompatibility group FII plasmids encoding CTX-M-14 among extended-spectrum beta-lactamase-producing Escherichia coli in Hong Kong, 1996-2008. Diagn Microbiol Infect Dis 2012;73:182-6
78. Ho PL, Lo WU, Lai EL, et al. Escherichia coli O25b-ST131 is an important cause of antimicrobial-resistant infections in women with uncomplicated cystitis. J Antimicrob Chemother 2012;67:2534-5
79. Ho PL, Lo WU, Yeung MK, et al. Complete sequencing of pNDM-HK encoding NDM-1 carbapenemase from a multidrug-resistant Escherichia coli strain isolated in Hong Kong. PLoS One 2011;6: e17989
80. Tsang KY, Luk S, Lo JY, et al. Hong Kong experiences the 'Ultimate superbug': NDM-1 Enterobacteriaceae. Hong Kong Med J 2012;18:439-41
81. Ho PL, Lo WU, Wong RC, et al. Complete sequencing of the FII plasmid pHK01, encoding CTX-M-14, and molecular analysis of its variants among Escherichia coli from Hong Kong. J Antimicrob Chemother 2011;66:752-6
82. Ye QH, Lau Y, Liang B, et al. Antimicrobial resistance, genotypic characterization and pulsed-field gel electrophoresis typing of extended spectrum beta-lactamases-producing clinical Escherichia coli strains in Macao, China. Chin Med J 2011;124:2701-7
83. Lin CF, Hsu SK, Chen CH, et al. Genotypic detection and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a regional hospital in central Taiwan. J Med Microbiol 2010;59:665-71
84. Shu JC, Chia JH, Kuo AJ, et al. A 7-year surveillance for ESBL-producing Escherichia coli and Klebsiella pneumoniae at a university hospital in Taiwan: the increase of CTX-M-15 in the ICU. Epidemiol Infect 2010;138:253-63
85. Chung HC, Lai CH, Lin JN, et al. Bacteremia caused by extended-spectrum-beta-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality. Antimicrob Agents Chemother 2012;56:618-22
86. Chen CJ, Wu TL, Lu PL, et al. Closely Related NDM-1-Encoding Plasmids from Escherichia coli and Klebsiella pneumoniae in Taiwan. PLoS One 2014;9:e104899
87. Yan JJ, Tsai LH, Wu JJ. Emergence of the IMP-8 metallo-beta-lactamase in the Escherichia coli ST131 clone in Taiwan. Int J Antimicrob Agents 2012;40:281-2
88. Kao CY, Udval U, Wu HM, et al. First report of the prevalence of extended-spectrum beta-lactamase producing Escherichia coli in two Mongolian hospitals. Infect Genet Evol 2014;25:66-8
89. Yokota S, Sato T, Okubo T, et al. Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan. Chemotherapy 2012;58:52-9
90. Chong Y, Yakushiji H, Ito Y, et al. Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a long-term study from Japan. Eur J Clin Microbiol Infect Dis 2011;30:83-7
91. Nakamura T, Komatsu M, Yamasaki K, et al. Epidemiology of Escherichia coli, Klebsiella species, and Proteus mirabilis strains producing extended-spectrum beta-lactamases from clinical samples in the Kinki Region of Japan. Am J Clin Pathol 2012;137:620-6
92. Yaita K, Aoki K, Suzuki T, et al. Epidemiology of extended-spectrum beta-lactamase producing Escherichia coli in the stools of returning Japanese travelers, and the risk factors for colonization. PLoS One 2014;9:e98000
93. Matsumura Y, Yamamoto M, Higuchi T, et al. Prevalence of plasmid-mediated AmpC beta-lactamase-producing Escherichia coli and spread of the ST131 clone among extended-spectrum beta-lactamase-producing E. coli in Japan. Int J Antimicrob Agents 2012;40:158-62
94. Koyano S, Saito R, Nagai R, et al. Molecular characterization of carbapenemase-producing clinical isolates of Enterobacteriaceae in a teaching hospital, Japan. J Med Microbiol 2013;62:446-50
95. Hayakawa K, Miyoshi-Akiyama T, Kirikae T, et al. Molecular and epidemiological characterization of IMP-type metallo-beta-lactamase-producing Enterobacter cloacae in a Large tertiary care hospital in Japan. Antimicrob Agents Chemother 2014;58:3441-50
96. Yano H, Ogawa M, Endo S, et al. High frequency of IMP-6 among clinical isolates of metallo-beta-lactamase-producing Escherichia coli in Japan. Antimicrob Agents Chemother 2012;56:4554-5
97. Mizuno Y, Yamaguchi T, Matsumoto T. A first case of New Delhi metallo-beta-lactamase-7 in an Escherichia coli ST648 isolate in Japan. J Infect Chemother 2014;20(12):814-16
98. Yamamoto T, Takano T, Iwao Y, et al. Emergence of NDM-1-positive capsulated Escherichia coli with high resistance to serum killing in Japan. J Infect Chemother 2011;17:435-9
99. Saito R, Takahashi R, Sawabe E, et al. First report of KPC-2 Carbapenemase-producing Klebsiella pneumoniae in Japan. Antimicrob Agents Chemother 2014;58:2961-3
100. Jeong SH, Bae IK, Kim D, et al. First outbreak of Klebsiella pneumoniae clinical isolates producing GES-5 and SHV-12 extended-spectrum beta-lactamases in Korea. Antimicrob Agents Chemother 2005;49:4809-10
101. Kim J, Kwon Y, Pai H, et al. Survey of Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases: prevalence of SHV-12 and SHV-2a in Korea. J Clin Microbiol 1998;36:1446-9
102. Ryoo NH, Kim EC, Hong SG, et al. Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J Antimicrob Chemother 2005;56:698-702
103. Kim J, Lim YM, Rheem I, et al. CTX-M and SHV-12 beta-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea. FEMS Microbiol Lett 2005;245:93-8
104. Song W, Lee H, Lee K, et al. CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum beta-lactamase in clinical isolates of Escherichia coli from Korea. J Med Microbiol 2009;58:261-6
105. Park SH, Byun JH, Choi SM, et al. Molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15. BMC Infect Dis 2012;12:149
106. Lee K, Lee M, Shin JH, et al. Prevalence of plasmid-mediated AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae in Korea. Microb Drug Resist 2006;12:44-9
107. Yoo JS, Byeon J, Yang J, et al. High prevalence of extended-spectrum beta-lactamases and plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae isolated from long-term care facilities in Korea. Diagn Microbiol Infect Dis 2010;67: 261-5
108. Yoo JS, Kim HM, Koo HS, et al. Nosocomial transmission of NDM-1-producing Escherichia coli ST101 in a Korean hospital. J Antimicrob Chemother 2013;68:2170-2
109. Hong SK, Yong D, Kim K, et al. First outbreak of KPC-2-producing Klebsiella pneumoniae sequence type 258 in a hospital in South Korea. J Clin Microbiol 2013;51: 3877-9
110. Hawser SP, Bouchillon SK, Hoban DJ, et al. Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007. Antimicrob Agents Chemother 2009;53:3280-4
111. Kaur N, Sharma S, Malhotra S, et al. Urinary tract infection: aetiology and antimicrobial resistance pattern in infants from a tertiary care hospital in northern India. J Clin Diagn Res 2014;8:DC01-3
112. Roy S, Krishnan R, Mukherjee S, et al. Prevalence of ST131 virulence-associated strains among CTX-M-producing Escherichia coli in the gut of hospitalized neonates in India. Diagn Microbiol Infect Dis 2013;77:158-9
113. Bora A, Hazarika NK, Shukla SK, et al. Prevalence of blaTEM, blaSHV and blaCTX-M genes in clinical isolates of Escherichia coli and Klebsiella pneumoniae from Northeast India. Indian J Pathol Microbiol 2014;57:249-54
114. Mohamudha Parveen R, Manivannan S, Harish BN, et al. Study of CTX-M type of extended spectrum beta-lactamase among nosocomial isolates of escherichia coli and klebsiella pneumoniae in south India. Indian J Microbiol 2012;52:35-40
115. Hussain A, Ewers C, Nandanwar N, et al. Multiresistant uropathogenic Escherichia coli from a region in India where urinary tract infections are endemic: genotypic and phenotypic characteristics of sequence type 131 isolates of the CTX-M-15 extended-spectrum-beta-lactamase-producing lineage. Antimicrob Agents Chemother 2012;56:6358-65
116. Bhattacharya D, Thamizhmani R, Bhattacharya H, et al. Emergence of New Delhi metallo-beta-lactamase 1 (NDM-1) producing and multidrug resistant uropathogens causing urinary tract infections in Andaman Islands, India. Microb Drug Resist 2013;19:457-62
117. Lascols C, Hackel M, Marshall SH, et al. Increasing prevalence and dissemination of NDM-1 metallo-beta-lactamase in India: data from the SMART study (2009). J Antimicrob Chemother 2011;66:1992-7
118. Roy S, Singh AK, Viswanathan R, et al. Transmission of imipenem resistance determinants during the course of an outbreak of NDM-1 Escherichia coli in a sick newborn care unit. J Antimicrob Chemother 2011;66:2773-80
119. Khajuria A, Praharaj AK, Kumar M, et al. Emergence of Escherichia coli, Co-Producing NDM-1 and OXA-48 Carbapenemases, in Urinary Isolates, at a tertiary care centre at central india. J Clin Diagn Res 2014;8:DC01-4
120. Potron A, Poirel L, Verdavaine D, et al. Importation of KPC-2-producing Escherichia coli from India. J Antimicrob Chemother 2012;67:242-3
121. Mirza SH, Salman M, Khurshid U, et al. CTX-M ESBL enzyme in Escherichia coli from urology patients in Rawalpindi, Pakistan. J Pak Med Assoc 2006;56:576-8
122. Habeeb MA, Haque A, Iversen A, et al. Occurrence of virulence genes, 16S rRNA methylases, and plasmid-mediated quinolone resistance genes in CTX-M-producing Escherichia coli from Pakistan. Eur J Clin Microbiol Infect Dis 2014;33:399-409
123. Hussain M, Hasan F, Shah AA, et al. Prevalence of class A and AmpC beta-lactamases in clinical Escherichia coli isolates from Pakistan Institute of Medical Science, Islamabad, Pakistan. Jpn J Infect Dis 2011;64:249-52
124. Day KM, Ali S, Mirza IA, et al. Prevalence and molecular characterization of Enterobacteriaceae producing NDM-1 carbapenemase at a military hospital in Pakistan and evaluation of two chromogenic media. Diagn Microbiol Infect Dis 2013;75:187-91
125. Day KM, Salman M, Kazi B, et al. Prevalence of NDM-1 carbapenemase in patients with diarrhoea in Pakistan and evaluation of two chromogenic culture media. J Appl Microbiol 2013;114:1810-16
126. Farzana R, Shamsuzzaman SM, Mamun KZ, et al. Antimicrobial susceptibility pattern of extended spectrum beta-lactamase producing gram-negative bacteria isolated from wound and urine in a tertiary care hospital, Dhaka City, Bangladesh. Southeast Asian J Trop Med Public Health 2013;44: 96-103
127. Lina TT, Khajanchi BK, Azmi IJ, et al. Phenotypic and Molecular Characterization of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Bangladesh. PLoS One 2014;9:e108735
128. Islam MA, Nabi A, Rahman M, et al. Prevalence of faecal carriage of NDM-1-producing bacteria among patients with diarrhoea in Bangladesh. J Med Microbiol 2014;63:620-2
129. Chander A, Shrestha CD. Prevalence of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae urinary isolates in a tertiary care hospital in Kathmandu, Nepal. BMC Res Notes 2013;6:487
130. Sharma A, Shrestha S, Upadhyay S, et al. Clinical and bacteriological profile of urinary tract infection in children at Nepal medical college teaching hospital. Nepal Med College J 2011;13:24-6
131. Pradhan R, Shrestha U, Gautam SC, et al. Bloodstream infection among children presenting to a general hospital outpatient clinic in urban Nepal. PLoS One 2012;7: e47531
132. Bell JM, Turnidge JD, Gales AC, et al. Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). Diagn Microbiol Infect Dis 2002;42: 193-8
133. Koh TH, Wang GC, Sng LH, et al. CTX-M and plasmid-mediated AmpC-producing Enterobacteriaceae Singapore. Emerg Infect Dis 2004;10:1172-4
134. Tan TY, Ng LS, He J, et al. CTX-M and ampC beta-lactamases contributing to increased prevalence of ceftriaxone-resistant Escherichia coli in Changi General Hospital, Singapore. Diagn Microbiol Infect Dis 2010;66:210-13
135. Koh TH, Sng LH, Wang G, et al. Emerging problems with plasmid-mediated DHA and CMY AmpC beta-lactamases in Enterobacteriaceae in Singapore. Int J Antimicrob Agents 2007;30:278-80
136. Koh TH, Cao D, Tee NW, et al. Escherichia coli with bla(IMP-8) in Singapore. Antimicrob Agents Chemother 2014;58:617
137. Apisarnthanarak A, Kiratisin P, Saifon P, et al. Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study. Am J Infect Control 2007;35:606-12
138. Kiratisin P, Apisarnthanarak A, Laesripa C, et al. Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agents Chemother 2008;52: 2818-24
139. Singtohin S, Chanawong A, Lulitanond A, et al. CMY-2, CMY-8b, and DHA-1 plasmid-mediated AmpC beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from a university hospital, Thailand. Diagn Microbiol Infect Dis 2010;68:271-7
140. Rimrang B, Chanawong A, Lulitanond A, et al. Emergence of NDM-1-and IMP-14a-producing Enterobacteriaceae in Thailand. J Antimicrob Chemother 2012;67:2626-30
141. Ho WS, Balan G, Puthucheary S, et al. Prevalence and characterization of multidrug-resistant and extended-spectrum beta-lactamase-producing Escherichia coli from pediatric wards of a Malaysian hospital. Microb Drug Resist 2012;18: 408-16
142. Hashim R, Shukor S, Ahmad N. Phenotypic and genotypic characterization of carbapenemase producing Enterobacteriaceae. Asia-Pacific Congress of Clinical Microbiology and Infection, 26-29 November 2014. Kuala Lumpur
143. Karuniawati A, Saharman YR, Lestari DC. Detection of carbapenemase encoding genes in Enterobacteriace, Pseudomonas aeruginosa, and Acinetobacter baumanii isolated from patients at Intensive Care Unit Cipto Mangunkusumo Hospital in 2011. Acta Med Indones 2013;45:101-6
144. Johnson DM, Biedenbach DJ, Jones RN. In vitro evaluation of broad-spectrum beta-lactams in the philippines medical centers: role of fourth-generation cephalosporins. The philippines antimicrobial resistance study group. Diagn Microbiol Infect Dis 1999;35:291-7
145. Tian GB, Garcia J, Adams-Haduch JM, et al. CTX-M as the predominant extended-spectrum beta-lactamases among Enterobacteriaceae in Manila, Philippines. J Antimicrob Chemother 2010;65:584-6
146. Copur Cicek A, Saral A, Ozad Duzgun A, et al. Nationwide study of Escherichia coli producing extended-spectrum beta-lactamases TEM, SHV and CTX-M in Turkey. J Antibiot (Tokyo) 2013;66:647-50
147. Yumuk Z, Afacan G, Nicolas-Chanoine MH, et al. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15. J Antimicrob Chemother 2008;62:284-8
148. Poirel L, Yilmaz M, Istanbullu A, et al. Spread of NDM-1-producing Enterobacteriaceae in a neonatal intensive care unit in Istanbul, Turkey. Antimicrob Agents Chemother 2014;58:2929-33
149. Kader AA, Kumar AK. Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia. Saudi Med J 2004;25:570-4
150. Kader AA, Angamuthu K. Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia. Saudi Med J 2005;26:956-9
151. Dortet L, Poirel L, Al Yaqoubi F, et al. NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman. Clin Microbiol Infect 2012;18:E144-8
152. Zowawi HM, Sartor AL, Balkhy HH, et al. Molecular Characterization of Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae in the Countries of the Gulf Cooperation Council: dominance of OXA-48 and NDM Producers. Antimicrob Agents Chemother 2014;58:3085-90
153. Baroud M, Dandache I, Araj GF, et al. Underlying mechanisms of carbapenem resistance in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases. Int J Antimicrob Agents 2013;41:75-9
154. Johnson JR, Oswald E, O'Bryan TT, et al. Phylogenetic distribution of virulence-associated genes among Escherichia coli isolates associated with neonatal bacterial meningitis in the Netherlands. J Infect Dis 2002;185:774-84
155. Yun KW, Kim HY, Park HK, et al. Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in children. J Microbiol Immunol Infect 2014;47:455-61
156. Florea C, Usein CR, Condei M, et al. Virulence characteristics of Escherichia coli isolates from children with urinary tract infections. Roum Arch Microbiol Immunol 2007;66:41-3
157. Sakran W, Smolkin V, Odetalla A, et al. Community-Acquired Urinary Tract Infection in Hospitalized Children: etiology and Antimicrobial Resistance. A Comparison Between First Episode and Recurrent Infection. Clin Pediatr (Phila) 2014. [Epub ahead of print]
158. Simonsen KA, Anderson-Berry AL, Delair SF, et al. Early-onset neonatal sepsis. Clin Microbiol Rev 2014;27:21-47
159. Nagao M. A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals. Clin Microbiol Infect 2013;19:852-8
160. Kim B, Kim J, Seo MR, et al. Clinical characteristics of community-acquired acute pyelonephritis caused by ESBL-producing pathogens in South Korea. Infection 2013;41:603-12
161. Lausch KR, Fuursted K, Larsen CS, et al. Colonisation with multi-resistant Enterobacteriaceae in hospitalised Danish patients with a history of recent travel: a cross-sectional study. Travel Med Infect Dis 2013;11:320-3
162. Ko YJ, Moon HW, Hur M, et al. Fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Korean community and hospital settings. Infection 2013;41:9-13
163. Geser N, Stephan R, Korczak BM, et al. Molecular identification of extended-spectrum-beta-lactamase genes from Enterobacteriaceae isolated from healthy human carriers in Switzerland. Antimicrob Agents Chemother 2012;56:1609-12
164. Ho PL, Chan J, Lo WU, et al. Dissemination of plasmid-mediated fosfomycin resistance fosA3 among multidrug-resistant Escherichia coli from livestock and other animals. J Appl Microbiol 2013;114:695-702
165. Ho PL, Chow KH, Lai EL, et al. Extensive dissemination of CTX-M-producing Escherichia coli with multidrug resistance to 'critically important' antibiotics among food animals in Hong Kong, 2008-10. J Antimicrob Chemother 2011;66:765-8
166. Tian GB, Wang HN, Zou LK, et al. Detection of CTX-M-15, CTX-M-22, and SHV-2 extended-spectrum beta-lactamases (ESBLs) in Escherichia coli fecal-sample isolates from pig farms in China. Foodborne Pathog Dis 2009;6:297-304
167. Liu BT, Yang QE, Li L, et al. Dissemination and characterization of plasmids carrying oqxAB-bla CTX-M genes in Escherichia coli isolates from food-producing animals. PloS One 2013;8: e73947
168. Zheng H, Zeng Z, Chen S, et al. Prevalence and characterisation of CTX-M beta-lactamases amongst Escherichia coli isolates from healthy food animals in China. Int J Antimicrob Agents 2012;39:305-10
169. Jiang HX, Tang D, Liu YH, et al. Prevalence and characteristics of beta-lactamase and plasmid-mediated quinolone resistance genes in Escherichia coli isolated from farmed fish in China. J Antimicrob Chemother 2012;67:2350-3
170. Rao L, Lv L, Zeng Z, et al. Increasing prevalence of extended-spectrum cephalosporin-resistant Escherichia coli in food animals and the diversity of CTX-M genotypes during 2003-2012. Vet Microbiol 2014;172:534-41
171. Harada K, Nakai Y, Kataoka Y. Mechanisms of resistance to cephalosporin and emergence of O25b-ST131 clone harboring CTX-M-27 beta-lactamase in extraintestinal pathogenic Escherichia coli from dogs and cats in Japan. Microbiol Immunol 2012;56:480-5
172. Kameyama M, Chuma T, Yabata J, et al. Prevalence and Epidemiological Relationship of CMY-2 AmpC beta-Lactamase and CTX-M extended-spectrum beta-lactamase-producing escherichia coli isolates from broiler Farms in Japan. J Vet Med Sci 2013;75(8):1009-15
173. Harada K, Morimoto E, Kataoka Y, et al. Clonal spread of antimicrobial-resistant Escherichia coli isolates among pups in two kennels. Acta Vet Scand 2011;53:11
174. Tamang MD, Nam HM, Gurung M, et al. Molecular characterization of CTX-M beta-lactamase and associated addiction systems in Escherichia coli circulating among cattle, farm workers, and the farm environment. Appl Environ Microbiol 2013;79:3898-905
175. Tamang MD, Nam HM, Kim SR, et al. Prevalence and molecular characterization of CTX-M beta-lactamase-producing Escherichia coli isolated from healthy swine and cattle. Foodborne Pathog Dis 2013;10: 13-20
176. World Economic Forum. Global Risks An Initiative of the Risk Response Network. In: Howell L, editor. Eight Edition. 2013. p. 28-35
177. Kresken M, Pfeifer Y, Hafner D, et al. Occurrence of multidrug resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany: extended-spectrum beta-lactamases and the role of fosfomycin. Int J Antimicrob Agents 2014;44:295-300
178. Hsueh PR, Hoban DJ, Carmeli Y, et al. Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region. J Infect 2011;63:114-23
179. Ghartey JP, Smith BC, Chen Z, et al. Lactobacillus crispatus dominant vaginal microbiome is associated with inhibitory activity of female genital tract secretions against Escherichia coli. PLoS One 2014;9: e96659
180. Brumbaugh AR, Mobley HL. Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine. Expert Rev Vaccines 2012;11:663-76
181. Ruppe E, Lixandru B, Cojocaru R, et al. Relative fecal abundance of extended-spectrum-beta-lactamase-producing Escherichia coli strains and their occurrence in urinary tract infections in women. Antimicrob Agents Chemother 2013;57: 4512-17
182. Huttner B, Haustein T, Uckay I, et al. Decolonization of intestinal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial. J Antimicrob Chemother 2013;68:2375-82
183. Gronberg-Hernandez J, Sunden F, Connolly J, et al. Genetic control of the variable innate immune response to asymptomatic bacteriuria. PLoS One 2011;6:e28289
184. Trivedi D, Jena PK, Seshadri S. Colicin E2 Expression in Lactobacillus brevis DT24, A Vaginal Probiotic Isolate, against Uropathogenic Escherichia coli. ISRN urology 2014;2014:869610
185. Jeong HS, Bae IK, Shin JH, et al. Prevalence of plasmid-mediated quinolone resistance and its association with extended-spectrum beta-lactamase and AmpC beta-lactamase in Enterobacteriaceae. Korean J Lab Med 2011;31:257-64
186. Jiang Y, Zhou Z, Qian Y, et al. Plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in China. J Antimicrob Chemother 2008;61:1003-6
187. Yan JJ, Wu JJ, Ko WC, et al. Plasmid-mediated 16S rRNA methylases conferring high-level aminoglycoside resistance in Escherichia coli and Klebsiella pneumoniae isolates from two Taiwanese hospitals. J Antimicrob Chemother 2004;54: 1007-12
188. Yang J, Ye L, Wang W, et al. Diverse prevalence of 16S rRNA methylase genes armA and rmtB amongst clinical multidrug-resistant Escherichia coli and Klebsiella pneumoniae isolates. Int J Antimicrob Agents 2011;38:348-51
189. Cai JC, Zhou HW, Zhang R, et al. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother 2008;52:2014-18
190. Liu Z, Li W, Wang J, et al. Identification and characterization of the first Escherichia coli strain carrying NDM-1 gene in China. PLoS One 2013;8:e66666
191. Wei Z, Yu T, Qi Y, et al. Coexistence of plasmid-mediated KPC-2 and IMP-4 carbapenemases in isolates of Klebsiella pneumoniae from China. J Antimicrob Chemother 2011;66:2670-1
192. Kim JS, Kim J, Kim SJ, et al. Characterization of CTX-M-type extended-spectrum beta-lactamase-producing diarrheagenic Escherichia coli isolates in the Republic of Korea during 2008-2011. J Microbiol Biotechnol 2014;24:421-6
193. Nahid F, Khan AA, Rehman S, et al. Prevalence of metallo-beta-lactamase NDM-1-producing multi-drug resistant bacteria at two Pakistani hospitals and implications for public health. J Infect Public Health 2013;6:487-93
194. Talukdar PK, Rahman M, Rahman M, et al. Antimicrobial resistance, virulence factors and genetic diversity of Escherichia coli isolates from household water supply in Dhaka, Bangladesh. PloS One 2013;8: e61090
195. Xia E, Khong WX, Marimuthu K, et al. Draft Genome sequence of a multidrug-resistant New Delhi Metallo-beta-Lactamase-1 (NDM-1)-producing escherichia coli isolate obtained in Singapore. Genome Announc 2013;19(6): e01020-13
196. Tian GB, Adams-Haduch JM, Bogdanovich T, et al. PME-1, an extended-spectrum beta-lactamase identified in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2011;55:2710-13